mo, average disease activity (DAS28) 5,2±1,7. CKD was defined as the presence of markers of renal impairment (proteinuria≥1+, hematuria≥2+ or leucocyturia≥2+) and/or eGFR<60 ml/min/1,73m 2 (using CKD-EPI formula) persistent beyond 3 months. The extent of multi-morbid environment was rated using Cumulative Illness Rating Score (CIRS) [2]. CIRS was calculated using the 5 score scale (0-4) to assess 14 major organ systems of the body (0-56). Results: The prevalence of CKD was 82,3% (172), and 30,1% (63) had eGFR<60 ml/min/1,73m, and 50,2% pts had CKD stage 2. The range of proteinuria was 12,4%. In group of pts with CKD 3-5 stage the prevalence of arterial hypertension (AH) was 84%, ischemic heart disease (IHD) -63,5%, diabetes militants 2 22%, oncology 12,7%. Mean CIRS value in RA pts was 15 [10;19] scores. The eGFR was independent of the RA duration 01, p=0,86) and RA activity (r=0,09, p=0,17). There was found the strongest correlation of eGFR with CIRS (r=-0,61, p<0,01), age (r=0,58; p<0,05), 34, p<0,01), 28, p<0,05), 17; r=0,35), uric acid levels (r=-0,37), as well as with hemoglobin level (r=0,19) and HAQ scores (r=0,31; r=0,32). No correlation was found between eGFR and oncology, gender, VAS score, and ESR, CRP, cholesterol (p>0,05). Conclusions: CKD is a serious condition associated with premature mortality, decreased quality of life, and increased health-care expenditures, but it doesn't consider as comorbid disorder of RA. The CKD prevalence is greater among aged RA pts than in general population and it has a stronger correlation with multimorbid burden than traditional factors. Compromised renal function, apart from the age, is of dominant importance in pts management issues, limiting the range of available effective therapies, thus, aggravating RA natural course on one side, and inducing and catalyzing the severity of dysmetabolic syndrome, AH and anemia -on the other. . However, its role in the diagnosis of CTS in patients with RA has been poorly investigated. Objectives: The aim of this study is to evaluate the US findings at carpal tunnel level in a cohort of patients with RA, focusing on those with a clinical diagnosis of CTS. Methods: Patients with RA fulfilling the ACR/EULAR 2010 classification criteria were consecutively enrolled. The diagnosis of CTS was made according to the American Academy of Neurology practice parameter for CTS [2]. The MSUS assessment was carried out using a MyLab Twice (Esaote SPA) US system working with a 18-22 MHz linear probe. The power Doppler (PD) frequency was set between 7.5 and 11.3 MHz. The following grey scale (GS) US parameters were assessed at the carpal tunnel level: cross-sectional area (CSA) of the median nerve at the carpal tunnel inlet (at the level of the pisiform and scaphoid bones), presence of flexor tenosynovitis and palmar radio-carpal synovitis (both in GS and PD), presence of crystal macro-aggregates and marked bone profile irregularities. The median nerve was considered enlarged if its CSA was more than 12 mm 2 . We evaluated the presence of intra-neural PD signals at the carpal inlet and scored its entity (0=no PD signal, 1=one single vessel within median nerve, 2=two or three single or two confluent vessels and 3=more than three single or more than two confluent vessels). PD was considered "positive" if grade 1 or more was found. Results: We included 40 RA patients. CTS was diagnosed in 19 out of 80 wrists (23.8%) and in 13 out of 40 RA patients (32.5%). Enlarged median nerve was found in 3 out of 19 wrists with CTS (15.8%) and in 6 out of 61 wrists without CTS (9.8%). Flexor tenosynovitis was found in 7 out of 19 wrists with CTS (36.8%) and in 5 out of 61 wrists without CTS (8.2%). Palmar radio-carpal synovitis was found in 2 out of 19 wrists with CTS (10.5%) and in 3 out of 61 wrists without CTS (4.9%). Crystal macro-aggregates were not detected in any of the scanned wrists. Marked bone profile irregularities were found in 2 out of 19 wrists with CTS (10.5%) and in 14 out of 61 wrists without CTS (23%). Positive intra-neural PD was found in 9 out of 19 wrists with CTS (47.4%) and in 9 out of 61 wrists without CTS (14.7%). Conclusions: These preliminary results suggest that MSUS could be a useful tool in the diagnosis of CTS also in patients with RA. Intra-neural PD and flexor tenosynovitis were the most frequently MSUS abnormalities detected in RA patients with CTS. The inflammatory involvement of the tendinous and joint structures which are part of the carpal tunnel could lead to median nerve compression and CTS symptoms and should be considered in the MSUS assessment of CTS. Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by bone, cartilage and muscle loss. While bone and cartilage damage have been extensively studied in the past, the effects of RA on volume and composition of hand muscles have not yet been studied. This situation is surprising, since visible hand muscle atrophy is a hallmark of RA and quantification of muscle composition is of growing interest. Objectives: Quantitative assessment of hand muscle volume and fat using MRI. Methods: A random forest based method was used to segment hand muscle in T1 weighted MR scans of 76 RA patients (37 males, 26-87 years, mean 61 years). The segmentation procedure is fully automated but allows for manual corrections of wrongly segmented areas. Multimodal registration of the muscle segmentation masks to MR Dixon Fat Fraction images was used for fat quantification. Outcome parameters were absolute hand and muscle volume (V
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